`
`
`
`Paper No. ___
`Date Filed: Feb. 6, 2017
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`JANSSEN ONCOLOGY, INC.,
`Patent Owner.
`
`________________
`
`Case IPR2016-01332
`Patent 8,822,438
`
`________________
`
`
`JOINT NOTICE OF CHANGE TO DUE DATE 1
`
`
`
`IPR2016-01332
`Patent No. 8,822,438
`
`Mylan Pharmaceuticals Inc. (“Petitioner”) and Janssen Oncology, Inc.
`
`(“Patent Owner”) have conferred and reached an agreement regarding the
`
`extension of Due Date 1 as set forth in the Scheduling Order issued on January 10,
`
`2017 (Paper No. 22). In light of the above, the parties jointly request entry of the
`
`following changes to the schedule:
`
`
`
`Previous Due Date
`
`Newly Stipulated Date
`
`DUE DATE 1
`
`Mar. 1, 2017
`
`Mar. 8, 2017
`
`
`
`Respectfully submitted,
`
`By:/Dianne B. Elderkin/
`Dianne B. Elderkin
`Registration No. 28,598
`Counsel for Patent Owner
`
`By:/ Brandon M. White/ (with consent)
`Brandon M. White
`Registration No. 52,354
`Counsel for Petitioner
`
`
`
`
`
`
`
`1
`
`Date: Feb, 6, 2017
`
`
`Date: Feb. 6, 2017
`
`
`
`
`
`
`
`IPR2016-01332
`Patent No. 8,822,438
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing JOINT
`
`
`
`NOTICE OF CHANGE TO DUE DATE 1 was served on counsel of record on
`
`February 6, 2017 by filing this document through the End-to-End System, as well
`
`as delivering a copy via electronic mail to counsel of record for the Petitioner at the
`
`following addresses:
`
`Brandon M. White – bmwhite@perkinscoie.com
`Bryan D. Beel – bbeel@perkinscoie.com
`
`Respectfully submitted,
`
`/Dianne B. Elderkin/
`Dianne B. Elderkin
`Registration No. 28,598
`Counsel for Patent Owner
`
`
`
`2
`
`
`Date: Feb. 6, 2017
`
`
`
`
`
`
`
`
`
`
`
`